Herpes – Genital (HSV) / Adolescents and Adults
Acyclovir† 400 mg orally 3 times/day for 7–10 days
OR
Famciclovir 250 mg orally 3 times/day for 7–10 days
OR
Valacyclovir 1 g orally 2 times/day for 7–10 days
* Treatment can be extended if healing is incomplete after 10 days of therapy.
† Acyclovir 200 mg orally 5 times/day is also effective but is not recommended because of the frequency of dosing.
None
Acyclovir 800 mg orally 2 times/day for 5 days
OR
Acyclovir 800 mg orally 3 times/day for 2 days
OR
Famciclovir 1 g orally 2 times/day for 1 day
OR
Famciclovir 500 mg orally once, followed by 250 mg 2 times/day for 2 days
OR
Famciclovir 125 mg orally 2 times/day for 5 days
OR
Valacyclovir 500 mg orally 2 times/day for 3 days
OR
Valacyclovir 1 g orally once daily for 5 days
*Acyclovir 400 mg orally 3 times/day for 5 days is also effective but is not recommended because of frequency of dosing.
None
Acyclovir 400 mg orally 2 times/day
OR
Valacyclovir 500 mg orally once a day*
OR
Valacyclovir 1 g orally once a day
OR
Famciclovir 250 mg orally 2 times/day
* Valacyclovir 500 mg once a day might be less effective than other valacyclovir or acyclovir dosing regimens for persons who have frequent recurrences (i.e., ≥10 episodes/year)
None
Recurrences are less frequent after the first episode of HSV-1 genital herpes, compared with genital HSV-2 genital herpes, and genital shedding rapidly decreases during the first year of infection. No data are available regarding the efficacy of suppressive therapy for preventing transmission among persons with HSV-1 genital herpes infection. Because of the decreased risk for recurrences and shedding, suppressive therapy for HSV-1 genital herpes should be reserved for those with frequent recurrences through shared clinical decision making between the patient and the provider.
Please see – https://wwwdev.cdc.gov/std/treatment-guidelines/herpes.htm#SevereDisease